Rigel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:RIGL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 Feb 25	SellUS$59,653	Raymond Furey	Individual	2,787	US$21.93
05 Feb 25	SellUS$200,075	Raul Rodriguez	Individual	9,352	US$21.93
05 Feb 25	SellUS$80,615	Dean Schorno	Individual	3,770	US$21.93
05 Feb 25	SellUS$83,836	David Santos	Individual	3,921	US$21.93

Insider Trading Volume

Insider Buying: RIGL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of RIGL?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	240,124	1.34%
Hedge Funds	2,282,679	12.8%
General Public	5,207,713	29.2%
Institutions	10,132,442	56.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 59.53% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.79%	BlackRock, Inc.	1,748,107	US$35.5m	12%	no data
8.6%	Morgan Stanley, Investment Banking and Brokerage Investments	1,536,645	US$31.2m	5.2%	no data
6.45%	Armistice Capital LLC	1,152,000	US$23.4m	-25%	0.57%
6.33%	Soleus Capital Management, L.P.	1,130,679	US$23.0m	21%	1.61%
5.67%	The Vanguard Group, Inc.	1,012,931	US$20.6m	2.81%	no data
2.3%	Assenagon Asset Management S.A.	410,778	US$8.4m	-7.01%	0.01%
2.25%	Geode Capital Management, LLC	402,051	US$8.2m	0.6%	no data
2.13%	State Street Global Advisors, Inc.	380,515	US$7.7m	3.46%	no data
2.11%	Acadian Asset Management LLC	376,366	US$7.7m	-10.8%	0.02%
1.68%	Renaissance Technologies LLC	299,709	US$6.1m	111%	0.01%
1.36%	CM Management, LLC	242,500	US$4.9m	-16.4%	4.29%
1.13%	Jacobs Levy Equity Management Inc	202,089	US$4.1m	14%	0.02%
0.97%	JPMorgan Chase & Co, Brokerage and Securities Investments	172,830	US$3.5m	825%	no data
0.95%	Hillsdale Investment Management Inc.	170,100	US$3.5m	815%	0.13%
0.9%	Macquarie Investment Management Business Trust	160,000	US$3.3m	0%	no data
0.86%	Goldman Sachs Group, Investment Banking and Securities Investments	154,171	US$3.1m	234%	no data
0.84%	Raul Rodriguez	150,487	US$3.1m	14.7%	no data
0.82%	Northern Trust Global Investments	145,839	US$3.0m	1.1%	no data
0.78%	Connor, Clark & Lunn Investment Management Ltd.	139,128	US$2.8m	42%	0.01%
0.72%	Norges Bank Investment Management	129,506	US$2.6m	0%	no data
0.67%	SEI Investments Management Corporation	119,362	US$2.4m	34.4%	no data
0.66%	Qube Research & Technologies Ltd	117,957	US$2.4m	0%	no data
0.61%	Voya Investment Management LLC	108,587	US$2.2m	-54.9%	no data
0.48%	Los Angeles Capital Management LLC	86,001	US$1.7m	15.4%	0.01%
0.48%	Ensign Peak Advisors, Inc.	85,878	US$1.7m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/19 05:44
End of Day Share Price	2025/03/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rigel Pharmaceuticals, Inc. is covered by 26 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Birchenough	Barclays
Clarence Powell	BMO Capital Markets Equity Research
James Birchenough	BMO Capital Markets Equity Research